サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ロングリードシーケンス市場- 世界の産業規模、シェア、動向、機会、予測、2017年～2027年：コンポーネント別、技術別、ワークフロー別、用途別、エンドユーザー別、企業別、地域別セグメント
市場調査レポート
商品コード
1289651

ロングリードシーケンス市場- 世界の産業規模、シェア、動向、機会、予測、2017年～2027年：コンポーネント別、技術別、ワークフロー別、用途別、エンドユーザー別、企業別、地域別セグメント

Long Read Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Component, By Technology, By Workflow, By Application, By End User, By Region, By company and By Region
出版日: | 発行: TechSci Research | ページ情報: 英文 113 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

ロングリードシーケンス市場- 世界の産業規模、シェア、動向、機会、予測、2017年～2027年：コンポーネント別、技術別、ワークフロー別、用途別、エンドユーザー別、企業別、地域別セグメント
出版日: 2023年06月01日
発行: TechSci Research
ページ情報: 英文 113 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

ロングリードシーケンスの世界市場は、予測期間2023-2027年に目覚ましい成長を遂げると予測されています。

主な要因としては、遺伝性疾患の新興国市場の拡大、研究開発活動に対する政府支援の拡大、技術の広範な開拓などが市場の成長を後押ししています。ロングリードシーケンスは、第3世代シーケンシングとも呼ばれ、研究が進められているDNAシーケンシング技術です。一度に10,000～100,000塩基対の長いDNA配列の塩基配列を決定することができます。この技術により、他のDNA塩基配列決定法では通常必要とされるDNAの切断や増幅が不要となります。市場の成長を支えるその他の要因としては、研究開発活動の活発化、がんを含む遺伝性疾患患者の増加、臨床試験件数の増加、個別化医療の人気の高まり、医療診断のための最新手法の受け入れ拡大、医療機関における学術目的のシーケンス解析手法の利用拡大、世界人口の増加、無機的成長戦略の採用拡大、新興サブマーケットへの大きな可能性などが挙げられます。

遺伝性疾患の急増

色覚異常、ダウン症、嚢胞性線維症などの遺伝性疾患の世界の流行が、市場の成長を後押ししています。世界保健機関（WHO）によると、10,000を超える遺伝性疾患が単発性であることが知られており、ヒトDNA内の1つの遺伝子のエラーによって引き起こされます。ロングリードシーケンス法を用いれば、患者の全ゲノミクスを調べることができます。そのため、遺伝子疾患の治療におけるロングリードシーケンスの採用が増加しています。遺伝性疾患を患う患者数の増加も市場成長の一因です。世界保健機関（WHO）によると、重度の遺伝性疾患である鎌状赤血球貧血は、新生児の約72,000人が罹患しています。

研究開発活動に対する政府支援の増加

ロングリードシーケンス法を用いた研究の増加は、政府当局から多額の資金援助を受けており、これが市場成長の主な理由となっています。さらに、研究活動の増加が市場の成長を後押ししています。例えば、米国では、ゲノム研究開発プロジェクトは、米国国立衛生研究所（NIH）だけでなく、世界中の他の多くのグループからも資金提供を受けています。現在、数多くの研究活動が行われており、これはメーカーが新しく先進的なロングリードシーケンスを開発する際に有利になるとともに、ロングリードシーケンス市場に多くの機会をもたらすと予測されています。例えば、米国では、ゲノム研究開発プロジェクトは、米国国立衛生研究所（NIH）だけでなく、世界中の他の多くのグループからも資金提供を受けています。

技術の進歩

シーケンサーの技術的進歩の高まりが市場の成長を後押ししています。これらの進歩により、シーケンスの効率性、正確性、移植性が向上しています。例えば、SMRTシーケンサで生成されるロングリードは、可能性のある反復領域を網羅し、ゲノム全体を包括的に見ることができます。同様に、2018年、カリフォルニアのPacific Biosciences（PacBio）は、ソフトウェアの新バージョン、試薬を含む新しい消耗品、新しいSMRTセル（1M v3）からなるSequel Systemの機能強化を発表しました。

利用可能なカスタマイズ

TechSci Researchは、所定の市場データを使用して、企業の特定のニーズに応じたカスタマイズを提供します。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 世界のロングリードシーケンス市場に対するCOVID-19の影響

第4章 VOC (顧客の声)

第5章 エグゼクティブサマリー

第6章 世界のロングリードシーケンス市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • コンポーネント別（機器、消耗品、サービス）
    • 技術別（単一分子リアルタイムシーケンシング（SMRT）、ナノポアシーケンシング、その他）
    • ワークフロー別（プリシーケンス、シーケンス、データ分析）
    • 用途別（腫瘍学、感染症、希少疾患、遺伝性疾患、代謝性疾患、その他）
    • エンドユーザー別（病院およびクリニック、バイオテクノロジーおよび製薬会社、学術および調査機関、その他）
    • 地域別
    • 企業別（2021年）
  • マーケットマップ

第7章 北米のロングリードシーケンス市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • コンポーネント別
    • 技術別
    • ワークフロー別
    • 用途別
    • エンドユーザー別
    • 国別
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第8章 欧州のロングリードシーケンス市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • コンポーネント別
    • 技術別
    • ワークフロー別
    • 用途別
    • エンドユーザー別
    • 国別
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋のロングリードシーケンス市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • コンポーネント別
    • 技術別
    • ワークフロー別
    • 用途別
    • エンドユーザー別
    • 国別
  • アジア太平洋：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米のロングリードシーケンス市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • コンポーネント別
    • 技術別
    • ワークフロー別
    • 用途別
    • エンドユーザー別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカのロングリードシーケンス市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • コンポーネント別
    • 技術別
    • ワークフロー別
    • 用途別
    • エンドユーザー別
    • 国別
  • MEA：国別分析
    • 南アフリカのロングリードシーケンス
    • サウジアラビアのロングリードシーケンス
    • UAEのロングリードシーケンス

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向と発展

第14章 競合情勢

  • Agilent Technologies, Inc.
  • BGI Group
  • Bionano Genomics, Inc.
  • Circulomics Inc
  • Oxford Nanopore Technologies plc
  • Longas Technologies Pty Ltd
  • Novogene Co., Ltd.
  • Illumina, Inc.
  • F. Hoffmann-La Roche AG
  • Pacific Biosciences of California, Inc.
  • Quantapore, Inc.
  • QIAGEN NV
  • PerkinElmer, Inc
  • Thermo Fischer Scientific, Inc.
  • Takara Bio, Inc.

第15章 戦略的推奨事項

目次
Product Code: 13056

The global long-read sequencing market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include growing occurrences of genetic disorders, growing government support for R&D activities, and extensive development in technology are fueling the growth of the market. Long-read sequencing, also known as third-generation sequencing, is a DNA sequencing technique that is being researched. It can determine the nucleotide sequence of long sequences of DNA ranging between 10,000 and 100,000 base pairs at a time. This technology eliminates the need to cut up and then amplify DNA which is usually needed in other DNA sequencing methods. The other factors supporting the market's growth are, a rise in R&D activities, a growing number of patients with genetic diseases, including cancer, an increasing number of clinical trials, the rising popularity of personalized medicine, increasing acceptance of modern approaches for medical diagnostics, rising utilization of sequence analysis methodologies in medical institutes for academic purposes, rise in world population, growing adoption of inorganic growth strategies, and immense potential for emerging submarkets.

The surge in Incidences of Genetic Disorders

The increasing prevalence of genetic diseases, such as color blindness, Down's syndrome, cystic fibrosis, and others, across the globe is bolstering the growth of the market. According to the World Health Organization (WHO), more than 10,000 of the diseases are known to be monogenic, triggered by a single error in a single gene in the human DNA. With the help of long-read sequencing methods, the whole genomics of the patient can be examined. Thus, rising the adoption of long-read sequencing in the treatment of genetic conditions. The growing number of patients suffering from genetic diseases is also a contributing factor to the growth of the market. According to the World Health Organization (WHO), sickle cell anemia, a severe genetic condition, affects about 72,000 newborn babies.

Increasing Government Support for R&D Activities

The increasing research which uses long-read sequencing methods is being heavily funded by government authorities, which is a key reason for the growth of the market. Moreover, the rising number of research activities is augmenting the growth of the market. For instance, in the U.S., genomics research and development projects are funded through the National Institutes of Health (NIH) as well as numerous other groups from around the globe. Presently, numerous amounts of research activities are being performed, which is projected to give manufacturers an advantage as they develop new and advanced long-read sequencing, as well as to open many opportunities in the long-read sequencing market. For instance, in the U.S., genomics research and development projects are funded through the National Institutes of Health (NIH) as well as numerous other groups from around the globe.

Technological advancements

The rise in technological advancements in sequencers is propelling the growth of the market. These advancements have made sequencing more efficient, accurate, and portable. For instance, long reads generated by SMRT sequencers span around possible repetitive regions and give a comprehensive view of the whole genome. Similarly, in 2018, Pacific Biosciences of California (PacBio) announced the enhancements to their Sequel System, which comprises a new version of its software, new consumables including reagents, and a new SMRT Cell (1M v3).

Market Segmentation

The global long-read sequencing market is segmented into components, technology, workflow, application, end user, and company. Based on components, the market is divided into instruments, consumables, and services. Based on technology, the market is divided into single-molecule real-time sequencing (SMRT), nanopore sequencing, and others. Based on workflow, the market is divided into pre-sequencing, sequencing, and data analysis. Based on application, the market is divided into oncology, infectious diseases, rare diseases, genetic disorders, metabolic disorders, and others. Based on end-user, the market is divided into hospitals & clinics, biotechnology & pharmaceutical companies, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising incidences of hematologic malignancies in the country.

Market Players

Agilent Technologies, Inc., BGI Group, Bionano Genomics, Inc., Circulomics Inc, Oxford Nanopore Technologies plc, Longas Technologies Pty Ltd, Novogene Co., Ltd., Illumina, Inc., F. Hoffmann-La Roche AG, Pacific Biosciences of California, Inc., Quantapore, Inc., QIAGEN NV, PerkinElmer, Inc, Thermo Fischer Scientific, Inc., and Takara Bio, Inc. are some of the leading companies operating in the market.

Report Scope

In this report, global long-read sequencing market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Long Read Sequencing Market, By Component:

  • Instruments
  • Consumables
  • Services

Long Read Sequencing Market, By Technology:

  • Single-Molecule Real-Time Sequencing (SMRT)
  • Nanopore Sequencing
  • Others

Long Read Sequencing Market, By Workflow:

  • Pre-Sequencing
  • Sequencing
  • Data Analysis

Long Read Sequencing Market, By Application:

  • Oncology
  • Infectious Diseases
  • Rare Diseases
  • Genetic Disorders,
  • Metabolic Disorders
  • Others

Long Read Sequencing Market, By End User:

  • Hospitals & Clinics
  • Biotechnology & Pharmaceutical Companies,
  • Academic & Research Institutions
  • Others

Long Read Sequencing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Long Read Sequencing Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Long Read Sequencing Market

4. Voice of Customer

5. Executive Summary

6. Global Long Read Sequencing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component (Instruments, Consumables, Services)
    • 6.2.2. By Technology (Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing, Others)
    • 6.2.3. By Workflow (Pre-Sequencing, Sequencing, Data Analysis)
    • 6.2.4. By Application (Oncology, Infectious Diseases, Rare Diseases, Genetic Disorders, Metabolic Disorders, Others)
    • 6.2.5. By End User (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 6.2.6. By Region
    • 6.2.7. By Company (2021)
  • 6.3. Market Map

7. North America Long Read Sequencing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Technology
    • 7.2.3. By Workflow
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Long Read Sequencing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Workflow
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Mexico Long Read Sequencing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Workflow
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. Canada Long Read Sequencing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Workflow
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User

8. Europe Long Read Sequencing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Technology
    • 8.2.3. By Workflow
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Long Read Sequencing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Workflow
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Long Read Sequencing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Workflow
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Long Read Sequencing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Workflow
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Long Read Sequencing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Workflow
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Long Read Sequencing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Workflow
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Asia-Pacific Long Read Sequencing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Technology
    • 9.2.3. By Workflow
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Long Read Sequencing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Workflow
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. India Long Read Sequencing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Workflow
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Japan Long Read Sequencing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Workflow
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User
    • 9.3.4. South Korea Long Read Sequencing Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Component
        • 9.3.4.2.2. By Technology
        • 9.3.4.2.3. By Workflow
        • 9.3.4.2.4. By Application
        • 9.3.4.2.5. By End User
    • 9.3.5. Australia Long Read Sequencing Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Component
        • 9.3.5.2.2. By Technology
        • 9.3.5.2.3. By Workflow
        • 9.3.5.2.4. By Application
        • 9.3.5.2.5. By End User

10. South America Long Read Sequencing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Technology
    • 10.2.3. By Workflow
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Long Read Sequencing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Workflow
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Long Read Sequencing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Workflow
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Long Read Sequencing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Workflow
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Middle East and Africa Long Read Sequencing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Component
    • 11.2.2. By Technology
    • 11.2.3. By Workflow
    • 11.2.4. By Application
    • 11.2.5. By End User
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Long Read Sequencing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Component
        • 11.3.1.2.2. By Technology
        • 11.3.1.2.3. By Workflow
        • 11.3.1.2.4. By Application
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Long Read Sequencing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Component
        • 11.3.2.2.2. By Technology
        • 11.3.2.2.3. By Workflow
        • 11.3.2.2.4. By Application
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Long Read Sequencing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Component
        • 11.3.3.2.2. By Technology
        • 11.3.3.2.3. By Workflow
        • 11.3.3.2.4. By Application
        • 11.3.3.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Agilent Technologies, Inc.
  • 14.2. BGI Group
  • 14.3. Bionano Genomics, Inc.
  • 14.4. Circulomics Inc
  • 14.5. Oxford Nanopore Technologies plc
  • 14.6. Longas Technologies Pty Ltd
  • 14.7. Novogene Co., Ltd.
  • 14.8. Illumina, Inc.
  • 14.9. F. Hoffmann-La Roche AG
  • 14.10. Pacific Biosciences of California, Inc.
  • 14.11. Quantapore, Inc.
  • 14.12. QIAGEN NV
  • 14.13. PerkinElmer, Inc
  • 14.14. Thermo Fischer Scientific, Inc.
  • 14.15. Takara Bio, Inc.

15. Strategic Recommendations